Literature DB >> 25738068

Morphological Pattern of Cutaneous Adverse Drug Reactions due to Antiepileptic Drugs in Eastern India.

Punit Kumar Singh1, Mani Kant Kumar2, Dharmendra Kumar3, Prashant Kumar4.   

Abstract

INTRODUCTION: Cutaneous manifestations of adverse drug reactions are a common occurrence and need to be differentiated from other causes of similar manifestations. Antiepileptic drugs (AED) usually are responsible for severe cutaneous adverse drug reactions (CADR) like Stevens-Johnson Syndrome/Toxic epidermal necrolysis (SJS/TEN) and drug rash with eosinophillia and systemic symptoms (DRESS). There is paucity of published research regarding morphological pattern of CADR due to various antiepileptic drugs AED.
OBJECTIVE: To study the morphological patterns of CADR due to AED and common anticonvulsant drugs implicated particularly in severe CADR such as SJS/TEN and DRESS in a tertiary care teaching hospital in eastern India.
MATERIALS AND METHODS: A prospective, observational study was conducted over a period of 4 years from August 2009 to July 2013 after the approval of the Institutional Ethics Committee using self-reporting method for selection of cases. SETTINGS: All patients with CADR after AED consumption for various conditions presenting to the Dermatology outpatient department (OPD) and Pediatric OPD and Indoor patients of a tertiary care teaching hospital located in Rohtas district of Bihar were included in this study.
RESULTS: During the study period, 64 cases of severe CADRs were included in this study. Out of 64 patients, 28 were male and 36 were female with mean age 36.1 years (range 6 years to 72 years). Most common AED implicated for CADR was Phenytoin. Maculopapular rash was the most common cutaneous manifestation of ADRs (42.85%). Serious CADR like TEN and SSJS were more likely in patients prescribed Phenytoin and Carbemazepine simultaneously.
CONCLUSION: CADRs are a common occurrence and awareness about the same is essential for diagnosis and prevention. This study identified combined use of phenytoin and carbamezepine as a most important risk factor for serious CADR like SJS and TEN.

Entities:  

Keywords:  Maculopapular rash; Stevens-Johnson Syndrome/Toxic epidermal necrolysis

Year:  2015        PMID: 25738068      PMCID: PMC4347159          DOI: 10.7860/JCDR/2015/11701.5419

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  14 in total

1.  Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions.

Authors:  L Naldi; A Conforti; M Venegoni; M G Troncon; A Caputi; E Ghiotto; A Cocci; U Moretti; G Velo; R Leone
Journal:  Br J Clin Pharmacol       Date:  1999-12       Impact factor: 4.335

2.  Adverse cutaneous drug reactions: clinical pattern and causative agents in a tertiary care center in South India.

Authors:  David Pudukadan; Devinder Mohan Thappa
Journal:  Indian J Dermatol Venereol Leprol       Date:  2004 Jan-Feb       Impact factor: 2.545

Review 3.  Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs.

Authors:  J S Leeder
Journal:  Epilepsia       Date:  1998       Impact factor: 5.864

4.  Serum trace elements, glutathione, copper/zinc superoxide dismutase, and lipid peroxidation in epileptic patients with phenytoin or carbamazepine monotherapy.

Authors:  C S Liu; H M Wu; S H Kao; Y H Wei
Journal:  Clin Neuropharmacol       Date:  1998 Jan-Feb       Impact factor: 1.592

5.  Severe adverse cutaneous drug eruptions: epidemiological and clinical features.

Authors:  Inès Zaraa; Meriem Jones; Sondes Trojjet; Rym Cheikh Rouhou; Dalenda El Euch; Mourad Mokni; Amel Ben Osman
Journal:  Int J Dermatol       Date:  2011-07       Impact factor: 2.736

6.  Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population.

Authors:  Choong-Chor Chang; Chun-Lai Too; Shahnaz Murad; Suraiya Hani Hussein
Journal:  Int J Dermatol       Date:  2011-02       Impact factor: 2.736

7.  Adverse drug reaction monitoring in a secondary care hospital in South India.

Authors:  R Arulmani; S D Rajendran; B Suresh
Journal:  Br J Clin Pharmacol       Date:  2007-07-27       Impact factor: 4.335

8.  Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation.

Authors:  B M Kerr; K E Thummel; C J Wurden; S M Klein; D L Kroetz; F J Gonzalez; R H Levy
Journal:  Biochem Pharmacol       Date:  1994-06-01       Impact factor: 5.858

9.  Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians.

Authors:  Timir Y Mehta; Laxman M Prajapati; Bharti Mittal; Chaitanya G Joshi; Jayesh J Sheth; Dinesh B Patel; Dinkar M Dave; Ramesh K Goyal
Journal:  Indian J Dermatol Venereol Leprol       Date:  2009 Nov-Dec       Impact factor: 2.545

10.  The metabolism of carbamazepine in humans: steric course of the enzymatic hydrolysis of the 10,11-epoxide.

Authors:  G Bellucci; G Berti; C Chiappe; A Lippi; F Marioni
Journal:  J Med Chem       Date:  1987-05       Impact factor: 7.446

View more
  3 in total

Review 1.  Categorization and association analysis of risk factors for adverse drug events.

Authors:  Lina Zhou; Anamika Paul Rupa
Journal:  Eur J Clin Pharmacol       Date:  2017-12-08       Impact factor: 2.953

Review 2.  Genetic Markers for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in the Asian Indian Population: Implications on Prevention.

Authors:  Swapna S Shanbhag; Madhuri A Koduri; Chitra Kannabiran; Pragnya R Donthineni; Vivek Singh; Sayan Basu
Journal:  Front Genet       Date:  2021-01-12       Impact factor: 4.599

3.  Management of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: Looking Beyond Guidelines!

Authors:  Rajesh Kumar; Anupam Das; Sudip Das
Journal:  Indian J Dermatol       Date:  2018 Mar-Apr       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.